Immunic, inc. to participate in scientific and industry conferences in april

New york , april 1, 2025 /prnewswire/ --  immunic, inc.  (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following scientific and industry conferences in april: april 5-9: american academy of neurology (aan) 2025 annual meeting. members of immunic's management, medical and preclinical teams will attend this meeting in san diego, california.
IMUX Ratings Summary
IMUX Quant Ranking